{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:30:26Z","timestamp":1787027426830,"version":"build-2736575974"},"reference-count":325,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mtbio.2026.103466","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:11:03Z","timestamp":1784128263000},"page":"103466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineering cuproptosis with nanomedicine: Design, combination therapy, and translation in cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Dongsheng","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-7576","authenticated-orcid":false,"given":"Anguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.mtbio.2026.103466_bib1","doi-asserted-by":"crossref","first-page":"R877","DOI":"10.1016\/j.cub.2011.09.040","article-title":"Copper: an essential metal in biology","volume":"21","author":"Festa","year":"2011","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nchembio.72","article-title":"Mechanisms for copper acquisition, distribution and regulation","volume":"4","author":"Kim","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbpa.2010.01.003","article-title":"Human copper homeostasis: a network of interconnected pathways","volume":"14","author":"Lutsenko","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib4","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.3390\/biomedicines11112884","article-title":"SLC31A1 identifying a novel biomarker with potential prognostic and immunotherapeutic potential in pan-cancer","volume":"11","author":"Zhang","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","article-title":"Connecting copper and cancer: from transition metal signalling to metalloplasia","volume":"22","author":"Ge","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib6","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: 'copper That Cancer'","volume":"7","author":"Denoyer","year":"2015","journal-title":"Metallomics"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","article-title":"Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma","volume":"22","author":"Tsang","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"7501","key":"10.1016\/j.mtbio.2026.103466_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature13180","article-title":"Copper is required for oncogenic BRAF signalling and tumorigenesis","volume":"509","author":"Brady","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"Erler","year":"2009","journal-title":"Cancer Cell"},{"issue":"6586","key":"10.1016\/j.mtbio.2026.103466_bib10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103466_bib11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","article-title":"Mitochondrial metabolism promotes adaptation to proteotoxic stress","volume":"15","author":"Tsvetkov","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","article-title":"Cuproptosis: a copper-triggered modality of mitochondrial cell death","volume":"32","author":"Tang","year":"2022","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mtbio.2026.103466_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104396","article-title":"Polyphyllin VI, a saponin from Trillium tschonoskii maxim. induces apoptotic and autophagic cell death via the ROS triggered mTOR signaling pathway in non-small cell lung cancer","volume":"147","author":"Teng","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/cancers12010193","article-title":"Polyphyllin VI induces Caspase-1-Mediated pyroptosis via the induction of ROS\/NF-\u03baB\/NLRP3\/GSDMD signal axis in non-small cell lung cancer","volume":"12","author":"Teng","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.103466_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"22","key":"10.1016\/j.mtbio.2026.103466_bib19","article-title":"Cuproptosis induced by ROS responsive nanoparticles with Elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","article-title":"Wilson disease","volume":"4","author":"Cz\u0142onkowska","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"32","key":"10.1016\/j.mtbio.2026.103466_bib21","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1200\/JCO.2008.17.1579","article-title":"Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma","volume":"27","author":"O'Day","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"7684","key":"10.1016\/j.mtbio.2026.103466_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature25016","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.drudis.2020.04.003","article-title":"The combination of disulfiram and copper for cancer treatment","volume":"25","author":"Li","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2026.103466_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","article-title":"The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer","volume":"10","author":"Guo","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.103466_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.34133\/bmr.0094","article-title":"Copper-based nanomedicines for Cuproptosis-Mediated effective cancer treatment","volume":"28","author":"Noh","year":"2024","journal-title":"Biomater. Res."},{"issue":"13","key":"10.1016\/j.mtbio.2026.103466_bib30","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1039\/D5CS00083A","article-title":"Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond","volume":"54","author":"Mao","year":"2025","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103466_bib31","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/j.apsb.2025.07.007","article-title":"Nanomedicine strategies for cuproptosis: metabolic reprogramming and tumor immunotherapy","volume":"15","author":"Zhang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103466_bib32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jconrel.2023.08.055","article-title":"Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor","volume":"362","author":"Liu","year":"2023","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","article-title":"Targeting cuproplasia and cuproptosis in cancer","volume":"21","author":"Tang","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-024-01589-8","article-title":"Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103466_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1290592","article-title":"Research progress on cuproptosis in cancer","volume":"15","author":"Feng","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"6586","key":"10.1016\/j.mtbio.2026.103466_bib36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.abo3959","article-title":"Copper-induced cell death","volume":"375","author":"Kahlson","year":"2022","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib37","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","article-title":"Cuproptosis: a new form of programmed cell death","volume":"19","author":"Wang","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","article-title":"Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118867","article-title":"Getting out what you put in: copper in mitochondria and its impacts on human disease","volume":"1868","author":"Cobine","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2026.103466_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0300-483X(03)00159-8","article-title":"Copper toxicity, oxidative stress, and antioxidant nutrients","volume":"189","author":"Gaetke","year":"2003","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib41","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1073\/pnas.0810286106","article-title":"Three-dimensional structure of the human copper transporter hCTR1","volume":"106","author":"De Feo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib42","doi-asserted-by":"crossref","first-page":"C768","DOI":"10.1152\/ajpcell.00417.2012","article-title":"Cellular glutathione plays a key role in copper uptake mediated by human copper transporter 1","volume":"304","author":"Maryon","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib43","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.261258","article-title":"Regulation of the apico-basolateral trafficking polarity of the homologous copper-ATPases ATP7A and ATP7B","volume":"137","author":"Ruturaj","year":"2024","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib44","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1152\/physrev.00004.2006","article-title":"Function and regulation of human copper-transporting ATPases","volume":"87","author":"Lutsenko","year":"2007","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib45","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2006-02-003681","article-title":"The steap proteins are metalloreductases","volume":"108","author":"Ohgami","year":"2006","journal-title":"Blood"},{"issue":"5415","key":"10.1016\/j.mtbio.2026.103466_bib46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.284.5415.805","article-title":"Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase","volume":"284","author":"Rae","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103466_bib47","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1039\/C6MT00176A","article-title":"Copper trafficking to the secretory pathway","volume":"8","author":"Lutsenko","year":"2016","journal-title":"Metallomics"},{"issue":"22","key":"10.1016\/j.mtbio.2026.103466_bib48","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1002\/j.1460-2075.1996.tb00997.x","article-title":"Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking","volume":"15","author":"Petris","year":"1996","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2006.12.001","article-title":"The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis","volume":"5","author":"Leary","year":"2007","journal-title":"Cell Metab."},{"issue":"38","key":"10.1016\/j.mtbio.2026.103466_bib50","doi-asserted-by":"crossref","first-page":"23469","DOI":"10.1074\/jbc.272.38.23469","article-title":"The copper chaperone for superoxide dismutase","volume":"272","author":"Culotta","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.biocel.2009.11.007","article-title":"Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: emerging roles","volume":"42","author":"La Fontaine","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib52","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s42003-024-06716-2","article-title":"Leishmania major-induced alteration of host cellular and systemic copper homeostasis drives the fate of infection","volume":"7","author":"Paul","year":"2024","journal-title":"Commun. Biol."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103466_bib53","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1016\/S0021-9258(18)83589-X","article-title":"The role of glutathione in copper metabolism and toxicity","volume":"264","author":"Freedman","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2026.103466_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: overview of its protective roles, measurement, and biosynthesis","volume":"30","author":"Forman","year":"2009","journal-title":"Mol. Aspect. Med."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib55","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.3390\/ijms14036044","article-title":"The role of metallothionein in oxidative stress","volume":"14","author":"Ruttkay-Nedecky","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","article-title":"Elevated copper and oxidative stress in cancer cells as a target for cancer treatment","volume":"35","author":"Gupte","year":"2009","journal-title":"Cancer Treat Rev."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1039\/C6MT00202A","article-title":"Defining the human copper proteome and analysis of its expression variation in cancers","volume":"9","author":"Blockhuys","year":"2017","journal-title":"Metallomics"},{"issue":"48","key":"10.1016\/j.mtbio.2026.103466_bib58","doi-asserted-by":"crossref","first-page":"19507","DOI":"10.1073\/pnas.1318431110","article-title":"Bioavailable copper modulates oxidative phosphorylation and growth of tumors","volume":"110","author":"Ishida","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib59","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","article-title":"Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis","volume":"12","author":"Ramchandani","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103466_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105046","article-title":"FDX1 regulates cellular protein lipoylation through direct binding to LIAS","volume":"299","author":"Dreishpoon","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mtbio.2026.103466_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","article-title":"Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease","volume":"42","author":"Rowland","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1242\/dmm.009019","article-title":"Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease","volume":"5","author":"Rouault","year":"2012","journal-title":"Dis. Model. Mech."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib63","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bbamcr.2014.12.018","article-title":"Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability","volume":"1853","author":"Paul","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mtbio.2026.103466_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123523","article-title":"Disrupting intracellular redox homeostasis through copper-driven dual cell death to induce anti-tumor immunotherapy","volume":"324","author":"Wang","year":"2026","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.mtbio.2026.103466_bib65","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1021\/jacsau.4c00712","article-title":"Signaling mechanism of cuproptosis activating cGAS-STING immune pathway","volume":"4","author":"Zhu","year":"2024","journal-title":"JACS Au"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib66","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/mol.109.063172","article-title":"Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs","volume":"77","author":"Howell","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2004.09.007","article-title":"Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs","volume":"53","author":"Safaei","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib68","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccr.2010.04.011","article-title":"Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator","volume":"17","author":"Ishida","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2026.103466_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1055356","article-title":"The copper transporter CTR1 and cisplatin accumulation at the single-cell level by LA-ICP-TOFMS","volume":"9","author":"Schoeberl","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib70","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1158\/1535-7163.MCT-23-0876","article-title":"ATPase copper transporting beta (ATP7B) is a novel target for improving the therapeutic efficacy of docetaxel by disulfiram\/copper in human prostate cancer","volume":"23","author":"Song","year":"2024","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib71","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12943-025-02434-3","article-title":"Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance","volume":"24","author":"Du","year":"2025","journal-title":"Mol. Cancer"},{"issue":"17","key":"10.1016\/j.mtbio.2026.103466_bib72","article-title":"AKT1 phosphorylates FDX1 to promote cuproptosis resistance in triple-negative breast cancer","volume":"12","author":"Sun","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib73","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1753-4887.2010.00271.x","article-title":"Metabolic crossroads of iron and copper","volume":"68","author":"Collins","year":"2010","journal-title":"Nutr. Rev."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib75","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7548","key":"10.1016\/j.mtbio.2026.103466_bib76","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib77","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1016\/j.apsb.2024.05.012","article-title":"Mitophagy and cGAS-STING crosstalk in neuroinflammation","volume":"14","author":"Zhou","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103466_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122512","article-title":"Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA-cGAS-STING signaling","volume":"307","author":"Yu","year":"2024","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib79","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.apsb.2024.04.028","article-title":"Inhalable nanoparticles with enhanced cuproptosis and cGAS-STING activation for synergistic lung metastasis immunotherapy","volume":"14","author":"Yan","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103466_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177964","article-title":"Cuproptosis induced by curcumin interfering with proliferation and energy metabolism in colorectal cancer: 3D tumor model and computational simulations reveal curcumin inhibition of HSPD1 and CALCOCO2","volume":"1003","author":"Cao","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"7575","key":"10.1016\/j.mtbio.2026.103466_bib81","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib82","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"35","key":"10.1016\/j.mtbio.2026.103466_bib83","doi-asserted-by":"crossref","first-page":"23941","DOI":"10.1021\/acsnano.3c10588","article-title":"Tumor metabolism aiming Cu(2-x)S nanoagents mediate photothermal-derived cuproptosis and immune activation","volume":"18","author":"Zu","year":"2024","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib84","doi-asserted-by":"crossref","first-page":"10206","DOI":"10.1021\/acsnano.3c00326","article-title":"Type-I AIE photosensitizer loaded biomimetic system boosting cuproptosis to inhibit breast cancer metastasis and rechallenge","volume":"17","author":"Ning","year":"2023","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202213922","article-title":"Photothermally triggered copper payload release for Cuproptosis-Promoted cancer synergistic therapy","volume":"62","author":"Zhou","year":"2023","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"18","key":"10.1016\/j.mtbio.2026.103466_bib86","article-title":"Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"10","key":"10.1016\/j.mtbio.2026.103466_bib87","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1039\/D4EN00455H","article-title":"Copper oxide nanoparticles induce cuproptosis and ferroptosis through mitochondrial concatenation","volume":"11","author":"Jiang","year":"2024","journal-title":"Environ. Sci. Nano"},{"key":"10.1016\/j.mtbio.2026.103466_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102223","article-title":"Cuprous oxide nanocomposites with photothermal (PTT) and chemical dynamics (CDT) effects induce cuproptosis in breast cancer using the strategy of increasing inflow and reducing outflow","volume":"56","author":"Li","year":"2024","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib89","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1021\/acsnano.4c13753","article-title":"Cuproptosis-inducing functional nanocomposites for enhanced and synergistic cancer radiotherapy","volume":"19","author":"Jiang","year":"2025","journal-title":"ACS Nano"},{"issue":"25","key":"10.1016\/j.mtbio.2026.103466_bib90","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1021\/jacs.9b03457","article-title":"Synthesis of copper peroxide nanodots for H(2)O(2) self-supplying chemodynamic therapy","volume":"141","author":"Lin","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib91","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/s12951-024-02828-3","article-title":"Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103466_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123592","article-title":"Copper metal-organic framework-based multifaceted strategy for boosting cancer therapy via synergistic cuproptosis and disulfidptosis","volume":"325","author":"Wu","year":"2026","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103466_bib93","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1021\/acsmaterialslett.4c01142","article-title":"Inducing pyroptosis and cuproptosis using copper carriers for ROS-augmented effective cancer therapy","volume":"6","author":"Zhong","year":"2024","journal-title":"ACS Mater. Lett."},{"issue":"43","key":"10.1016\/j.mtbio.2026.103466_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204733","article-title":"An enzyme-engineered nonporous Copper(I) coordination polymer nanoplatform for Cuproptosis-Based synergistic cancer therapy","volume":"34","author":"Xu","year":"2022","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.mtbio.2026.103466_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202949","article-title":"Tumor microenvironment responsive hollow nanoplatform for triple amplification of oxidative stress to enhance Cuproptosis-Based synergistic cancer therapy","volume":"12","author":"Xu","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"43","key":"10.1016\/j.mtbio.2026.103466_bib96","doi-asserted-by":"crossref","first-page":"30053","DOI":"10.1021\/acsnano.4c11455","article-title":"Hollow calcium\/copper bimetallic amplifier for cuproptosis\/paraptosis\/apoptosis cancer therapy via Cascade reinforcement of endoplasmic reticulum stress and mitochondrial dysfunction","volume":"18","author":"Xu","year":"2024","journal-title":"ACS Nano"},{"issue":"27","key":"10.1016\/j.mtbio.2026.103466_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202405937","article-title":"Bioorthogonal Cu single-atom nanozyme for synergistic nanocatalytic therapy, photothermal therapy, cuproptosis and immunotherapy","volume":"63","author":"Wu","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"24","key":"10.1016\/j.mtbio.2026.103466_bib98","doi-asserted-by":"crossref","first-page":"21969","DOI":"10.1021\/acsnano.5c00012","article-title":"Enhanced cuproptosis via metabolic reprogramming using copper-delivering Co-N-C single-atom nanozyme","volume":"19","author":"Kim","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103466_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.138692","article-title":"A biodegradable self-cascading copper-based nanozyme for augmented cancer catalytic therapy and cuproptosis","volume":"701","author":"Liu","year":"2026","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2026.103466_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102442","article-title":"Dynamic polyphenol nanoparticles boost cuproptosis-driven metalloimmunotherapy of breast cancer","volume":"58","author":"Zhang","year":"2024","journal-title":"Nano Today"},{"issue":"14","key":"10.1016\/j.mtbio.2026.103466_bib101","doi-asserted-by":"crossref","first-page":"21001","DOI":"10.1021\/acsami.5c05104","article-title":"Atovaquone-coordinated copper-polyphenol nanoplatform orchestrates dual metabolic interference for synergistic cuproptosis and apoptosis","volume":"17","author":"Qin","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib102","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1186\/s12951-025-03722-2","article-title":"Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis\/ferroptosis mediated breast cancer therapy","volume":"23","author":"Liang","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib103","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1021\/acsnano.5b07521","article-title":"Biomineralization-inspired synthesis of copper sulfide\u2013ferritin nanocages as cancer theranostics","volume":"10","author":"Wang","year":"2016","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202409875","article-title":"Copper-based bio-coordination nanoparticle for enhanced pyroptosis-cuproptosis cancer immunotherapy through redox modulation and glycolysis inhibition","volume":"21","author":"Cun","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103466_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2025.115070","article-title":"Biomineralized Cu-Disulfiram nanoparticles potentiate colorectal cancer immunotherapy through synergistic cuproptosis and apoptosis","volume":"260","author":"Hu","year":"2025","journal-title":"Mater. Des."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib106","doi-asserted-by":"crossref","first-page":"13509","DOI":"10.1021\/acsami.3c17792","article-title":"Elesclomol-copper nanoparticles overcome multidrug resistance in cancer cells","volume":"16","author":"Wang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib107","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/acsabm.9b01014","article-title":"Apoferritin as a carrier of Cu(II) diethyldithiocarbamate and biomedical application for glutathione-responsive combination chemotherapy","volume":"3","author":"Li","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"issue":"48","key":"10.1016\/j.mtbio.2026.103466_bib108","doi-asserted-by":"crossref","first-page":"41118","DOI":"10.1021\/acsami.8b14940","article-title":"Disulfiram copper nanoparticles prepared with a stabilized metal ion ligand complex method for treating drug-resistant prostate cancers","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib109","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1016\/j.ymthe.2025.09.004","article-title":"Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemoresistance in PDAC","volume":"33","author":"Yu","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mtbio.2026.103466_bib110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-016-0183-z","article-title":"Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations","volume":"14","author":"Fasehee","year":"2016","journal-title":"J. Nanobiotechnol."},{"issue":"35","key":"10.1016\/j.mtbio.2026.103466_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404971","article-title":"Glutathione-scavenging Celastrol-Cu nanoparticles induce self-amplified cuproptosis for augmented cancer immunotherapy","volume":"36","author":"Lu","year":"2024","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.mtbio.2026.103466_bib112","article-title":"Stimulus-responsive copper complex nanoparticles induce cuproptosis for augmented cancer immunotherapy","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"35","key":"10.1016\/j.mtbio.2026.103466_bib113","article-title":"Mitochondria-targeted multifunctional nanoparticles combine cuproptosis and programmed cell Death-1 downregulation for cancer immunotherapy","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"43","key":"10.1016\/j.mtbio.2026.103466_bib114","doi-asserted-by":"crossref","first-page":"37544","DOI":"10.1021\/acsnano.5c05965","article-title":"Mitochondria-targeted dual-ion perturbator amplifies cuproptosis for enhanced melanoma immunotherapy and accelerated postoperative wound healing","volume":"19","author":"Du","year":"2025","journal-title":"ACS Nano"},{"issue":"23","key":"10.1016\/j.mtbio.2026.103466_bib115","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1039\/D5MH01047K","article-title":"Traceable nanoparticles with mitochondria-targeting pyruvate-Cu induce cuproptosis for enhanced triple-negative breast cancer therapy in a mouse model","volume":"12","author":"Peng","year":"2025","journal-title":"Mater. Horiz."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib116","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12896-026-01149-7","article-title":"Mitochondria-targeted CORM-401 nanoparticles inhibit A549 cells by triggering cuproptosis","volume":"26","author":"Shao","year":"2026","journal-title":"BMC Biotechnol."},{"issue":"27","key":"10.1016\/j.mtbio.2026.103466_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202308565","article-title":"Copper deposition in polydopamine nanostructure to promote cuproptosis by catalytically inhibiting copper exporters of tumor cells for cancer immunotherapy","volume":"20","author":"Chang","year":"2024","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54469-7","article-title":"Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy","volume":"15","author":"Guan","year":"2024","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.mtbio.2026.103466_bib119","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1158\/0008-5472.CAN-24-2558","article-title":"Targeting ATP7A-Dependent copper metabolic homeostasis induces cuproptosis and suppresses the progression of mutant KRAS-driven lung cancer","volume":"85","author":"Zhao","year":"2025","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103466_bib120","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1039\/D4SC04712E","article-title":"Copper depletion-induced tumor cuproptosis","volume":"16","author":"Zhou","year":"2025","journal-title":"Chem. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib121","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","article-title":"Mitochondrial copper depletion suppresses triple-negative breast cancer in mice","volume":"39","author":"Cui","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib122","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","article-title":"Influencing the tumor microenvironment: a phase II study of copper depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases","volume":"23","author":"Chan","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib123","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41523-021-00313-w","article-title":"Tetrathiomolybdate (TM)-Associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer","volume":"7","author":"Liu","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.mtbio.2026.103466_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121351","article-title":"Two birds with one stone: copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy","volume":"612","author":"Pan","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib125","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.apsb.2022.11.003","article-title":"Hollow copper sulfide nanoparticles carrying ISRIB for the sensitized photothermal therapy of breast cancer and brain metastases through inhibiting stress granule formation and reprogramming tumor-associated macrophages","volume":"13","author":"Tong","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.mtbio.2026.103466_bib126","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","article-title":"The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells","volume":"52","author":"Nagai","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mtbio.2026.103466_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103007","article-title":"Inhibiting the compensatory elevation of xCT collaborates with disulfiram\/copper-induced GSH consumption for cascade ferroptosis and cuproptosis","volume":"69","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202400018","article-title":"Recent advances in the biomedical applications of copper nanomaterial-mediated cuproptosis","volume":"4","author":"Wu","year":"2024","journal-title":"Adv Nanobiomed Res"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib131","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib132","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.7150\/thno.123080","article-title":"Cuproptosis-triggering nanomedicine boosts antitumor immunotherapy","volume":"16","author":"Wang","year":"2026","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib133","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1039\/D3CB00219E","article-title":"Engineered triphenylphosphonium-based, mitochondrial-targeted liposomal drug delivery system facilitates cancer cell killing actions of chemotherapeutics","volume":"5","author":"Sivagnanam","year":"2024","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.mtbio.2026.103466_bib134","article-title":"Advancements in mitochondrial-targeted nanotherapeutics: overcoming biological obstacles and optimizing drug delivery","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103466_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/bjbs.2024.13707","article-title":"Pioneering advances and innovative applications of mesoporous carriers for mitochondria-targeted therapeutics","volume":"81","author":"Al Tahan","year":"2024","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.mtbio.2026.103466_bib136","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting antioxidants to mitochondria by conjugation to lipophilic cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103466_bib137","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","article-title":"Delivery of bioactive molecules to mitochondria in vivo","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib138","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/bph.12461","article-title":"First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics","volume":"171","author":"Szeto","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"33","key":"10.1016\/j.mtbio.2026.103466_bib139","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib140","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/cbic.200900185","article-title":"Targeting mitochondria with organelle-specific compounds: strategies and applications","volume":"10","author":"Yousif","year":"2009","journal-title":"Chembiochem"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib141","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biology, and Disease, Cell"},{"issue":"18","key":"10.1016\/j.mtbio.2026.103466_bib142","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1002\/anie.201712027","article-title":"Simultaneous fenton-like ion delivery and glutathione depletion by MnO(2) -Based nanoagent to enhance chemodynamic therapy","volume":"57","author":"Lin","year":"2018","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib143","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/anie.201805664","article-title":"Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions","volume":"58","author":"Tang","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"22","key":"10.1016\/j.mtbio.2026.103466_bib144","doi-asserted-by":"crossref","first-page":"13704","DOI":"10.1016\/S0021-9258(18)33504-X","article-title":"Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis","volume":"257","author":"Griffith","year":"1982","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"34","key":"10.1016\/j.mtbio.2026.103466_bib146","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis inhibition for anticancer treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib147","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib148","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41467-017-00424-8","article-title":"Tumor-selective catalytic nanomedicine by nanocatalyst delivery","volume":"8","author":"Huo","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib149","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jacs.8b08714","article-title":"Self-assembled copper-amino acid nanoparticles for in situ glutathione \"AND\" H(2)O(2) sequentially triggered chemodynamic therapy","volume":"141","author":"Ma","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib151","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00204-014-1355-y","article-title":"Copper: toxicological relevance and mechanisms","volume":"88","author":"Gaetke","year":"2014","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib152","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Contr. Release"},{"issue":"31","key":"10.1016\/j.mtbio.2026.103466_bib153","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated Castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib154","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib155","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70011","article-title":"Navigating PROTACs in cancer therapy: advancements, challenges, and future Horizons","volume":"13","author":"Ibrahim","year":"2025","journal-title":"Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib156","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.apsb.2024.12.007","article-title":"Recent advances in the bench-to-bedside translation of cancer nanomedicines","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib157","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1021\/nn203293t","article-title":"Hydrophilic Cu9S5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo","volume":"5","author":"Tian","year":"2011","journal-title":"ACS Nano"},{"issue":"43","key":"10.1016\/j.mtbio.2026.103466_bib158","doi-asserted-by":"crossref","first-page":"15351","DOI":"10.1021\/ja106855m","article-title":"A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET\/CT imaging and photothermal ablation therapy","volume":"132","author":"Zhou","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib159","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1039\/C9CS00648F","article-title":"Multifunctional sonosensitizers in sonodynamic cancer therapy","volume":"49","author":"Son","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib160","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aa99ce","article-title":"Nanoparticle radio-enhancement: principles, progress and application to cancer treatment","volume":"63","author":"Kuncic","year":"2018","journal-title":"Phys. Med. Biol."},{"issue":"27","key":"10.1016\/j.mtbio.2026.103466_bib161","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.mtbio.2026.103466_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib163","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"issue":"6478","key":"10.1016\/j.mtbio.2026.103466_bib164","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"41","key":"10.1016\/j.mtbio.2026.103466_bib165","doi-asserted-by":"crossref","first-page":"30201","DOI":"10.1039\/D4RA04441J","article-title":"Metal\u2013organic frameworks in drug delivery: engineering versatile platforms for therapeutic applications","volume":"14","author":"Khafaga","year":"2024","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib166","first-page":"33","article-title":"Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy","volume":"5","author":"Guo","year":"2024","journal-title":"Biomater Transl"},{"key":"10.1016\/j.mtbio.2026.103466_bib167","article-title":"Cell membrane biomimetic nanoplatforms: a new strategy for immune escape and precision targeted therapy","volume":"35","author":"Feng","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"Pt A","key":"10.1016\/j.mtbio.2026.103466_bib168","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103466_bib169","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles in oncology: facing the PEG dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s44301-025-00014-4","article-title":"Beyond PEGylation: nanoparticle surface modulation for enhanced cancer therapy","volume":"1","author":"Taghavimandi","year":"2025","journal-title":"Health Nanotechnol"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib171","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib172","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers","volume":"11","author":"Sch\u00f6ttler","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.103466_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114154","article-title":"Customization of protein corona to reprogram cancer nanomedicines: mechanistic insights and therapeutic implications","volume":"386","author":"Lu","year":"2025","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib174","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib175","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12951-025-03677-4","article-title":"Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases","volume":"23","author":"Zeng","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib176","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12951-023-01974-4","article-title":"Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy","volume":"21","author":"Wei","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103466_bib177","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.2147\/IJN.S554821","article-title":"Bridging the gap: the role of advanced formulation strategies in the clinical translation of nanoparticle-based drug delivery systems","volume":"20","author":"Herdiana","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib178","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2010.04.008","article-title":"Translational considerations for cancer nanomedicine","volume":"146","author":"Stern","year":"2010","journal-title":"J. Contr. Release"},{"issue":"29","key":"10.1016\/j.mtbio.2026.103466_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502315","article-title":"Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape","volume":"21","author":"Desai","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103466_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110546","article-title":"Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mTORC1\/2 inhibition","volume":"382","author":"Geng","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib181","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib182","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/acs.chemmater.3c02323","article-title":"An intelligent cupreous nanoplatform with self-supplied H2O2 and Cu2+\/Cu+ conversion to boost cuproptosis and chemodynamic combined therapy","volume":"36","author":"Tian","year":"2024","journal-title":"Chem. Mater."},{"issue":"28","key":"10.1016\/j.mtbio.2026.103466_bib183","article-title":"Biomimetic nano-regulator that induces cuproptosis and lactate-depletion mediated ROS storm for metalloimmunotherapy of clear cell renal cell carcinoma","volume":"13","author":"Xu","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"20","key":"10.1016\/j.mtbio.2026.103466_bib184","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1039\/D5BM00954E","article-title":"Composite nano copper carrier combining cuproptosis and photodynamic therapy for spatiotemporal synergistic anti-tumor therapy","volume":"13","author":"Hu","year":"2025","journal-title":"Biomater. Sci."},{"issue":"29","key":"10.1016\/j.mtbio.2026.103466_bib185","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202504228","article-title":"Ultrasound-triggered nanoparticles induce cuproptosis for enhancing immunogenic sonodynamic therapy","volume":"37","author":"Huang","year":"2025","journal-title":"Adv. Mater."},{"issue":"26","key":"10.1016\/j.mtbio.2026.103466_bib186","doi-asserted-by":"crossref","first-page":"8107","DOI":"10.1021\/acs.nanolett.4c01864","article-title":"The convergence of sonodynamic therapy and cuproptosis in the dual-responsive biomimetic CytoNano for precision mitochondrial intervention in cancer treatment","volume":"24","author":"Li","year":"2024","journal-title":"Nano Lett."},{"issue":"23","key":"10.1016\/j.mtbio.2026.103466_bib187","article-title":"Carrier-free self-assembly nano-sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in glioblastoma therapy","volume":"11","author":"Zhu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"43","key":"10.1016\/j.mtbio.2026.103466_bib188","article-title":"Tumor microenvironment activated Cu crosslinked near-infrared sonosensitizers for visualized Cuproptosis-Enhanced sonodynamic cancer immunotherapy","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib189","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","article-title":"Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance","volume":"43","author":"Lei","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2026.103466_bib190","doi-asserted-by":"crossref","first-page":"14551","DOI":"10.2147\/IJN.S563439","article-title":"Tumor microenvironment reprogramming via copper-enriched black phosphorus nanoplatform for Cuproptosis-Sensitized low-dose radioimmunotherapy","volume":"20","author":"Chen","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2026.103466_bib191","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.actbio.2026.04.017","article-title":"Stimuli-responsive copper-iodide nanoparticles for low-dose X-ray-induced photodynamic therapy and enhanced cuproptosis","volume":"216","author":"Xu","year":"2026","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2026.103466_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113941","article-title":"Self-assembled copper chlorogenic acid nanoparticles: inducing pyroptosis and cuproptosis to activate antitumor immunity","volume":"384","author":"Zhou","year":"2025","journal-title":"J. Contr. Release"},{"issue":"23","key":"10.1016\/j.mtbio.2026.103466_bib193","article-title":"Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"32","key":"10.1016\/j.mtbio.2026.103466_bib194","article-title":"Copper-based nanotubes that enhance starvation therapy through cuproptosis for synergistic cancer treatment","volume":"12","author":"Han","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"43","key":"10.1016\/j.mtbio.2026.103466_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004647","article-title":"Colorectal tumor microenvironment-activated bio-decomposable and metabolizable Cu(2) O@CaCO(3) nanocomposites for synergistic oncotherapy","volume":"32","author":"Chang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103466_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.139625","article-title":"Dual-functional copper nanoplatform potentiates cuproptosis through p53 reactivation and metabolic reprogramming","volume":"706","author":"Ma","year":"2026","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2026.103466_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.128947","article-title":"Smart responsive nanoplatform via in situ forming disulfiram-copper ion chelation complex for cancer combination chemotherapy","volume":"415","author":"Meng","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib198","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2024.05.009","article-title":"A phase 1\/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma","volume":"120","author":"Huang","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.mtbio.2026.103466_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.148522","article-title":"Copper peroxide and cisplatin co-loaded silica nanoparticles-based trinity strategy for cooperative cuproptosis\/chemo\/chemodynamic cancer therapy","volume":"481","author":"He","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.mtbio.2026.103466_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106942","article-title":"Copper-coordinated nanomedicine for the concurrent treatment of lung cancer through the induction of cuproptosis and apoptosis","volume":"204","author":"Huang","year":"2025","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"33","key":"10.1016\/j.mtbio.2026.103466_bib201","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1039\/D2TB01150F","article-title":"Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis","volume":"10","author":"Lu","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2026.103466_bib202","article-title":"Cuproptosis-based layer-by-layer silk fibroin nanoplatform-loaded PD-L1 siRNA combining photothermal and chemodynamic therapy against metastatic breast cancer","volume":"29","author":"Li","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2026.103466_bib203","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jconrel.2022.11.003","article-title":"A nanoplatform reshaping intracellular osmolarity and redox homeostasis against colorectal cancer","volume":"352","author":"Shi","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103466_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113772","article-title":"Hydrogel-enabled ROS-GSH modulation for sustained copper-mediated chemodynamic therapy of oral squamous cell carcinoma","volume":"383","author":"Wu","year":"2025","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib205","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.chempr.2019.06.003","article-title":"Calcium-overload-mediated tumor therapy by calcium peroxide nanoparticles","volume":"5","author":"Zhang","year":"2019","journal-title":"Chem"},{"issue":"17","key":"10.1016\/j.mtbio.2026.103466_bib206","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202412802","article-title":"Biomineralization of copper-celastrol nanohybrids for synergistic antitumor therapy","volume":"21","author":"Li","year":"2025","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib207","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1021\/nn5002112","article-title":"Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles","volume":"8","author":"Guo","year":"2014","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib208","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2217\/nnm.10.85","article-title":"Copper sulfide nanoparticles for photothermal ablation of tumor cells","volume":"5","author":"Li","year":"2010","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib209","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1039\/c3nr06242b","article-title":"Cu7.2S4 nanocrystals: a novel photothermal agent with a 56.7% photothermal conversion efficiency for photothermal therapy of cancer cells","volume":"6","author":"Li","year":"2014","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/02656730701769841","article-title":"Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events","volume":"24","author":"Roti Roti","year":"2008","journal-title":"Int. J. Hyperther."},{"issue":"16","key":"10.1016\/j.mtbio.2026.103466_bib211","first-page":"4440","article-title":"Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size","volume":"60","author":"Kong","year":"2000","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib212","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10286020.2025.2530748","article-title":"Advances in drug design strategies for phototherapy based on tumor cell death mechanisms","volume":"28","author":"Chen","year":"2026","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.mtbio.2026.103466_bib214","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.2147\/IJN.S458520","article-title":"DHTPY-Cu@ZOL-Enhanced photodynamic therapy: a strategic platform for advanced treatment of drug-resistant bacterial wound infections","volume":"19","author":"Hou","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103466_bib215","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1016\/j.apsb.2022.12.021","article-title":"Newly developed gas-assisted sonodynamic therapy in cancer treatment","volume":"13","author":"Pan","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103466_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113830","article-title":"Biomimetic liposomal nanovesicles remodel the tumor immune microenvironment to augment sono-immunotherapy","volume":"383","author":"Zhao","year":"2025","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib217","first-page":"2542","article-title":"Long-term survival case of a non-small cell lung cancer bone metastasis patient treated with bone cement, radiation and gefitinib","volume":"25","author":"Hou","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib218","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/med.21998","article-title":"Revolutionizing the battle against locally advanced breast cancer: a comprehensive insight into neoadjuvant radiotherapy","volume":"44","author":"Kong","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"23","key":"10.1016\/j.mtbio.2026.103466_bib219","article-title":"Metal-organic-framework-derived carbon nanostructure augmented sonodynamic cancer therapy","volume":"30","author":"Pan","year":"2018","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103466_bib221","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jconrel.2024.10.043","article-title":"A pH and glutathione-responsive carbon monoxide-driven nano-herb delivery system for enhanced immunotherapy in colorectal cancer","volume":"376","author":"Yang","year":"2024","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib222","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1021\/acs.molpharmaceut.3c00427","article-title":"Effective treatment of SSTR2-Positive small cell lung cancer using (211)At-Containing targeted \u03b1-Particle therapy agent which promotes endogenous antitumor immune response","volume":"20","author":"Qin","year":"2023","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib223","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.apsb.2024.02.006","article-title":"Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103466_bib224","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jconrel.2023.11.050","article-title":"Co-delivery of oxaliplatin prodrug liposomes with bacillus Calmette-Gu\u00e9rin for chemo-immunotherapy of orthotopic bladder cancer","volume":"365","author":"Ma","year":"2024","journal-title":"J. Contr. Release"},{"issue":"33","key":"10.1016\/j.mtbio.2026.103466_bib225","doi-asserted-by":"crossref","first-page":"46635","DOI":"10.1021\/acsami.5c08888","article-title":"Copper-induced cuproptosis and immunogenic cell death synergize with radiotherapy and PD-1 blockade in osteosarcoma","volume":"17","author":"Yao","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib226","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103466_bib227","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.mtbio.2026.103466_bib228","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","article-title":"Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion","volume":"80","author":"Voli","year":"2020","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.mtbio.2026.103466_bib229","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.7150\/thno.37574","article-title":"STING activation in cancer immunotherapy","volume":"9","author":"Su","year":"2019","journal-title":"Theranostics"},{"issue":"6121","key":"10.1016\/j.mtbio.2026.103466_bib230","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"6230","key":"10.1016\/j.mtbio.2026.103466_bib231","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"issue":"6382","key":"10.1016\/j.mtbio.2026.103466_bib232","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"6506","key":"10.1016\/j.mtbio.2026.103466_bib234","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib235","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19","key":"10.1016\/j.mtbio.2026.103466_bib236","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","article-title":"Synthetic nanoparticles for vaccines and immunotherapy","volume":"115","author":"Irvine","year":"2015","journal-title":"Chem. Rev."},{"issue":"6382","key":"10.1016\/j.mtbio.2026.103466_bib237","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib238","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2287966","article-title":"Platinum-based drugs and hydrogel: a promising anti-tumor combination","volume":"30","author":"Yao","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mtbio.2026.103466_bib239","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jconrel.2022.06.022","article-title":"A targeted nanomodulator capable of manipulating tumor microenvironment against metastasis","volume":"348","author":"Tian","year":"2022","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib240","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/pharmaceutics14030512","article-title":"Nonviral delivery systems of mRNA vaccines for cancer gene therapy","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103466_bib241","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJN.S441112","article-title":"Iron-based nanovehicle delivering Fin56 for hyperthermia-boosted ferroptosis therapy against osteosarcoma","volume":"19","author":"Zhang","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"7524","key":"10.1016\/j.mtbio.2026.103466_bib242","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib243","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"15","key":"10.1016\/j.mtbio.2026.103466_bib244","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk3201","article-title":"Cellular Trojan Horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies","volume":"10","author":"Chen","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103466_bib245","article-title":"Copper\/iron-based intelligent nanoparticles self-amplify apoptosis\/ferroptosis\/cuproptosis in colorectal cancer","volume":"36","author":"Xue","year":"2026","journal-title":"Mater. Today Bio"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103466_bib246","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.7150\/thno.130381","article-title":"Bimetallic Cu\/Fe-MOF-based heterojunction sonozymes for triple amplification of sono-immunotherapy through activating tumor-specific cuproptosis and cGAS-STING pathway","volume":"16","author":"Liu","year":"2026","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib247","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.mtbio.2026.103466_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.216284","article-title":"Cuproptosis nanomedicine in cancer therapy: novel insights and future perspectives","volume":"523","author":"Wang","year":"2025","journal-title":"Coord. Chem. Rev."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib249","article-title":"Cuproptosis and cuproptosis-related genes: emerging potential therapeutic targets in breast cancer","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.mtbio.2026.103466_bib250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2019.06.031","article-title":"Rationally designed peptide-conjugated gold\/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy","volume":"308","author":"Yang","year":"2019","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib251","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/pharmaceutics17040479","article-title":"Applications of matrix Metalloproteinase-9-Related nanomedicines in tumors and vascular diseases","volume":"17","author":"Li","year":"2025","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib252","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic heterogeneity in human lung tumors","volume":"164","author":"Hensley","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib253","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1038\/s41467-019-11738-0","article-title":"Metabolic landscape of the tumor microenvironment at single cell resolution","volume":"10","author":"Xiao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103466_bib254","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7819-9-54","article-title":"A review of metallothionein isoforms and their role in pathophysiology","volume":"9","author":"Thirumoorthy","year":"2011","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103466_bib256","article-title":"Toxicity, gut microbiota and metabolome effects after copper exposure during early life in SD rats","volume":"433\u2013434","author":"Dai","year":"2020","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib257","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jat.3968","article-title":"Associations of exposure to metals with the risk of hypertension among an older population aged 40-75 years in rural southwest China","volume":"40","author":"Wang","year":"2020","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib258","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820904547","article-title":"Alteration of metal elements in radiation injury: Radiation-Induced copper accumulation aggravates intestinal damage","volume":"18","author":"Zhong","year":"2020","journal-title":"Dose Response"},{"issue":"9559","key":"10.1016\/j.mtbio.2026.103466_bib259","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","article-title":"Wilson's disease","volume":"369","author":"Ala","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson's disease and other neurological copper disorders","volume":"14","author":"Bandmann","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib261","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2010.180","article-title":"ATP7A-related copper transport diseases-emerging concepts and future trends","volume":"7","author":"Kaler","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib262","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/biomedicines13020351","article-title":"COMMD3 regulates copper metabolism via the ATOX1-ATP7A-LOX axis to promote multiple myeloma progression","volume":"13","author":"Wang","year":"2025","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib263","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","article-title":"Regulatory aspects on nanomedicines","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mtbio.2026.103466_bib264","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103466_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114708","article-title":"Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles","volume":"194","author":"Kumar","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103466_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154131","article-title":"Copper oxide nanoparticles induce pulmonary inflammation via triggering cellular cuproptosis","volume":"514","author":"Zhang","year":"2025","journal-title":"Toxicology"},{"key":"10.1016\/j.mtbio.2026.103466_bib267","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pneurobio.2014.01.002","article-title":"Metabolism and functions of copper in brain","volume":"116","author":"Scheiber","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mtbio.2026.103466_bib268","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1504802","article-title":"Mitochondrial pathways of copper neurotoxicity: focus on mitochondrial dynamics and mitophagy","volume":"17","author":"Aschner","year":"2024","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib269","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1804","article-title":"Immunotoxicity of nanomaterials in health and disease: current challenges and emerging approaches for identifying immune modifiers in susceptible populations","volume":"14","author":"Hofer","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103466_bib270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.874253","article-title":"Copper oxide nanoparticles stimulate the immune response and decrease antioxidant defense in mice after six-week inhalation","volume":"13","author":"Tulinska","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib271","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1039\/c3cs60064e","article-title":"Cytokines as biomarkers of nanoparticle immunotoxicity","volume":"42","author":"Elsabahy","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2026.103466_bib272","article-title":"Nanoparticle-Induced complement activation: implications for cancer nanomedicine","volume":"11","author":"La-Beck","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib273","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1038\/s41467-025-63488-x","volume":"16","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib274","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib275","first-page":"379","article-title":"Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research","volume":"24","author":"Anderson","year":"2009","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.mtbio.2026.103466_bib276","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cbpa.2020.12.005","article-title":"Mass spectrometry techniques for imaging and detection of metallodrugs","volume":"61","author":"Theiner","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib277","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1021\/acs.molpharmaceut.4c01368","article-title":"(64)Cu radiolabeled PDGFR\u03b2-Targeting affibody for PET imaging in pancreatic cancer","volume":"22","author":"Li","year":"2025","journal-title":"Mol. Pharm."},{"issue":"suppl_12","key":"10.1016\/j.mtbio.2026.103466_bib278","doi-asserted-by":"crossref","first-page":"xii33","DOI":"10.1093\/annonc\/mdx683","article-title":"Intratumoral immunotherapy: using the tumor as the remedy","volume":"28","author":"Marabelle","year":"2017","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib279","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib280","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1158\/2159-8290.CD-18-0044","article-title":"Mouse models for cancer immunotherapy research","volume":"8","author":"Olson","year":"2018","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib281","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103466_bib282","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib283","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103466_bib284","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"6378","key":"10.1016\/j.mtbio.2026.103466_bib285","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib286","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2026.103466_bib287","article-title":"Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2 Pt 1","key":"10.1016\/j.mtbio.2026.103466_bib288","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/1078-0432.CCR-06-0964","article-title":"Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors","volume":"13","author":"Berkenblit","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103466_bib289","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1550982","article-title":"Assessing the prognostic and therapeutic value of cuproptosis-related genes in colon adenocarcinoma patients","volume":"13","author":"Ye","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib290","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/molecules31030394","article-title":"Cuproptosis: biomarkers, mechanisms and treatments in diseases","volume":"31","author":"Wang","year":"2026","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib291","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.tips.2026.02.004","article-title":"Cuproptosis in cancer: emerging mechanism and therapeutic opportunities","volume":"47","author":"Qin","year":"2026","journal-title":"Trends Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib292","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1039\/d0mt00156b","article-title":"Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation","volume":"12","author":"Davis","year":"2020","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib293","first-page":"1","article-title":"Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study","volume":"6","author":"Brewer","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103466_bib294","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3265212","article-title":"Cuproptosis-Related LncRNA signature for predicting prognosis of hepatocellular carcinoma: a comprehensive analysis","volume":"2022","author":"Chen","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.mtbio.2026.103466_bib295","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.930041","article-title":"Comprehensive analysis of Cuproptosis-Related genes in immune infiltration and prognosis in Melanoma","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib296","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.03.030","article-title":"Proteogenomic analysis of human Colon cancer reveals new therapeutic opportunities","volume":"177","author":"Vasaikar","year":"2019","journal-title":"Cell"},{"issue":"6487","key":"10.1016\/j.mtbio.2026.103466_bib297","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"6294","key":"10.1016\/j.mtbio.2026.103466_bib298","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aaf2403","article-title":"Visualization and analysis of gene expression in tissue sections by spatial transcriptomics","volume":"353","author":"St\u00e5hl","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib299","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nnano.2017.67","article-title":"The evolving landscape of drug products containing nanomaterials in the United States","volume":"12","author":"D'Mello","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.103466_bib300","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1544393","article-title":"Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks","volume":"12","author":"Rodr\u00edguez-G\u00f3mez","year":"2025","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib301","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-021-08242-4","article-title":"A phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker","volume":"21","author":"Kelley","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mtbio.2026.103466_bib302","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.12688\/f1000research.16786.1","article-title":"Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): study protocol for a randomized controlled trial","volume":"7","author":"Jakola","year":"2018","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib303","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","article-title":"A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer","volume":"20","author":"Nechushtan","year":"2015","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103466_bib304","first-page":"1666","article-title":"Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer","volume":"9","author":"Redman","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib305","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.apsb.2025.11.003","article-title":"Cuproptosis-based nanomedicine in cancer metastasis synergistic therapy","volume":"16","author":"Zhou","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103466_bib306","article-title":"Nanocuproptosis for precision tumor immunotherapy","volume":"5","author":"He","year":"2025","journal-title":"Nano TransMed"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib307","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12967-025-06121-1","article-title":"Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications","volume":"23","author":"Cong","year":"2025","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103466_bib308","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41423-026-01387-x","article-title":"Tackling cuproptosis: from metabolic rewiring to therapeutic exploitation in cancer","volume":"23","author":"Hao","year":"2026","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103466_bib309","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nchembio807","article-title":"The role of iron regulatory proteins in mammalian iron homeostasis and disease","volume":"2","author":"Rouault","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103466_bib310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2016.23","article-title":"Mitonuclear communication in homeostasis and stress","volume":"17","author":"Quir\u00f3s","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib311","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrm.2017.110","article-title":"The mitochondrial UPR: mechanisms, physiological functions and implications in ageing","volume":"19","author":"Shpilka","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7033","key":"10.1016\/j.mtbio.2026.103466_bib312","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","article-title":"Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death","volume":"434","author":"Baines","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103466_bib313","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1039\/D5RA08728G","article-title":"Engineering combination nanomedicines to overcome cancer resistance","volume":"16","author":"Singh","year":"2026","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103466_bib314","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.apsb.2025.12.011","article-title":"Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: current applications, challenges, and future perspectives","volume":"16","author":"Shen","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100279","article-title":"Accelerating discoveries in cancer nanomedicine using AI","volume":"1","author":"Guan","year":"2025","journal-title":"Cell Biomaterials"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103466_bib316","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/j.apsb.2025.07.030","article-title":"Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: progress, challenges, and future directions","volume":"15","author":"Ren","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"13","key":"10.1016\/j.mtbio.2026.103466_bib317","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1073\/pnas.93.13.6814","article-title":"Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu","volume":"93","author":"Connett","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103466_bib318","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.3390\/ijms24119154","article-title":"Recent advances in (64)Cu\/(67)Cu-based radiopharmaceuticals","volume":"24","author":"Krasnovskaya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103466_bib319","article-title":"Clinically friendly smart hydrogel boosts cuproptosis and PD-L1 upregulation to enhance anti-tumor immunotherapy","volume":"35","author":"Fu","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103466_bib320","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103466_bib321","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.103466_bib322","article-title":"Circulating tumor DNA: a revolutionary approach for early detection and personalized treatment of bladder cancer","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib323","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.apsb.2021.07.001","article-title":"Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy","volume":"12","author":"Gou","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"24","key":"10.1016\/j.mtbio.2026.103466_bib324","first-page":"9416","article-title":"Analysis of clinical features, treatment, and prognosis of primary lymphoepithelioma-like carcinoma of the lung","volume":"26","author":"Hu","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103466_bib325","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s13063-019-3664-1","article-title":"Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols","volume":"20","author":"Park","year":"2019","journal-title":"Trials"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:46Z","timestamp":1787026546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426007118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":325,"alternative-id":["S2590006426007118"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103466","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering cuproptosis with nanomedicine: Design, combination therapy, and translation in cancer","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103466"}}